|
WARDS
|
|
Drug
|
Isolates tested
|
% Not
susceptible
|
%R
|
%I
|
| Piperacillin |
52
|
88,46%
|
76,92%
|
11,54%
|
| Piper/Tazob |
78
|
71,79%
|
47,44%
|
24,36%
|
| Ticarcillin |
65
|
83,08%
|
70,77%
|
12,31%
|
| Ticarc/Clav |
71
|
87,32%
|
71,83%
|
15,49%
|
| Ampic/Sulb |
49
|
40,82%
|
34,69%
|
6,12%
|
| |
|
|
|
|
| Ceftazidime |
106
|
75,47%
|
63,21%
|
12,26%
|
| Aztreonam |
80
|
88,75%
|
80,00%
|
8,75%
|
| Cefotaxime |
97
|
86,60%
|
81,44%
|
5,15%
|
| Cefepime |
69
|
68,12%
|
59,42%
|
8,70%
|
| |
|
|
|
|
| Imipenem |
99
|
27,27%
|
23,23%
|
4,04%
|
| |
|
|
|
|
| Gentamicin |
105
|
60,00%
|
49,52%
|
10,48%
|
| Tobramycin |
100
|
60,00%
|
49,00%
|
11,00%
|
| Amikacin |
106
|
63,21%
|
61,32%
|
1,89%
|
| Netilmicin |
59
|
57,63%
|
57,63%
|
0,00%
|
| |
|
|
|
|
| Ciprofloxacin |
104
|
74,04%
|
73,08%
|
0,96%
|
|
|
|
ICU
|
|
Isolates tested
|
% Not
susceptible
|
%R
|
%I
|
|
45
|
93,33%
|
93,33%
|
0,00%
|
|
80
|
78,75%
|
58,75%
|
20,00%
|
|
67
|
97,01%
|
91,04%
|
5,97%
|
|
76
|
89,47%
|
82,89%
|
6,58%
|
|
54
|
46,30%
|
40,74%
|
5,56%
|
|
|
|
|
|
|
106
|
87,74%
|
84,91%
|
2,83%
|
|
89
|
98,88%
|
93,26%
|
5,62%
|
|
97
|
96,91%
|
93,81%
|
3,09%
|
|
65
|
90,77%
|
72,31%
|
18,46%
|
|
|
|
|
|
|
104
|
30,77%
|
16,35%
|
14,42%
|
|
|
|
|
|
|
106
|
78,30%
|
56,60%
|
21,70%
|
|
96
|
72,92%
|
60,42%
|
12,50%
|
|
107
|
79,44%
|
74,77%
|
4,67%
|
|
59
|
81,36%
|
79,66%
|
1,69%
|
|
|
|
|
|
|
104
|
91,35%
|
90,38%
|
0,96%
|
|
